Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Autor: Klamer, TA, Bots, SH, Neefs, J, Tulevski, II, Ruijter, HMD, Somsen, GA, de, Groot JR, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Current Problems in Cardiology, 47(10), 1. Mosby Inc.

Stroke prevention and rate or rhythm control are crucial in the management of atrial fibrillation (AF). There is recent evidence for benefit of early rhythm control, yet rate control is the first choice in elderly patients. However, the efficacy and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a319a5182f8f6820101d3f1ef144e3d
https://doi.org/10.1016/j.cpcardiol.2021.100996

Evaluation of non-invasive imaging parameters in coronary microvascular disease: a systematic review

Autor: Groepenhoff, F, Klaassen, RGM, Valstar, GB, Bots, SH, Onland-Moret, NC, Den, Ruijter HM, Leiner, T, Eikendal, ALM, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: BMC Medical Imaging, Vol 21, Iss 1, Pp 1-23 (2021)
BMC Medical Imaging
BMC Medical Imaging, 21(1), 1. BioMed Central
BMC medical imaging, 21(1):5. BioMed Central

Background Coronary microvascular dysfunction (CMD) is an important underlying cause of angina pectoris. Currently, no diagnostic tool is available to directly visualize the coronary microvasculature. Invasive microvascular reactivity testing is the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf2acf678a82b76128f5045ae1a14dc3
https://doi.org/10.1186/s12880-020-00535-7

Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature

Autor: Bots, SH, Groepenhoff, F, Eikendal, ALM, Tannenbaum, C, Rochon, PA, Regitz-Zagrosek, V, Miller, VM, Day, D, Asselbergs, FW, den Ruijter, HM

Publikováno v: JACC. Heart failure, 7(3), 258-266. Elsevier BV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::8d1fba00dc12a9874437a5288a23677b
https://pure.amc.nl/en/publications/adverse-drug-reactions-to-guidelinerecommended-heart-failure-drugs-in-women-a-systematic-review-of-the-literature(8d7bfdb8-48cb-4a54-8a65-f2c07569de9d).html

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease

Autor: Bots, SH, van, der Graaf Y, Nathoe, HM, de, Borst GJ, Kappelle, JL, Visseren, FL, Westerink, J, Group, SMART Study, UU BETA RESEARCH

Publikováno v: Cardiovascular Diabetology, 15. BioMed Central
Cardiovascular Diabetology [E], 15(1). BioMed Central
Cardiovascular Diabetology

BACKGROUND: Strict glycaemic control in patients with type 2 diabetes has proven to have microvascular benefits while the effects on CVD and mortality are less clear, especially in high risk patients. Whether strict glycaemic control would reduce the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::387a39e1937ae761b130e0b76e102e4e
https://doi.org/10.1186/s12933-016-0418-1

Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example.

Autor: Bots SH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands., Belitser S; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands., Groenwold RHH; Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands., Durán CE; Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands., Riera-Arnau J; Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain., Schultze A; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK., Messina D; Agenzia Regionale di Sanita', Florence Toscana, Italy., Segundo E; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Douglas I; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK., Carreras JJ; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)., Garcia-Poza P; Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Gini R; Agenzia Regionale di Sanita', Florence Toscana, Italy., Huerta C; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)., Martín-Pérez M; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)., Martin I; Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands., Paoletti O; Agenzia Regionale di Sanita', Florence Toscana, Italy., Bissacco CA; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Correcher-Martínez E; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)., Souverein P; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands., Urchuequía A; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)., Villalobos F; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Sturkenboom MCJM; Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands., Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.

Publikováno v: American journal of epidemiology [Am J Epidemiol] 2024 Jul 03. Date of Electronic Publication: 2024 Jul 03.